Drugs / Fuzheng Huayu tablet
Fuzheng Huayu tablet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04279197 | Apr 2020 → Mar 2021 | postinflammatory pulmonary fibrosis | ShuGuang Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fuzheng Huayu tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04279197 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Fuzheng Huayu tablet (FZHY), a traditional Chinese medicine known for its anti-liver fibrotic properties” PMID 40135237 ↗ Mar 2025 |
| Route | Oral | “FZHY, administration: 0.4g/tablet, 1.6g/time, 3 times/day, oral; administered half an hour after the meal.” NCT04279197 ↗ |